• LAST PRICE
    12.2500
  • TODAY'S CHANGE (%)
    Trending Down-0.0400 (-0.3255%)
  • Bid / Lots
    12.2400/ 1
  • Ask / Lots
    12.2700/ 4
  • Open / Previous Close
    12.4000 / 12.2900
  • Day Range
    Low 12.2400
    High 12.5300
  • 52 Week Range
    Low 3.7987
    High 14.3800
  • Volume
    65,958
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 12.29
TimeVolumeBVS
09:32 ET288912.4
09:35 ET145212.3537
09:44 ET219612.26
09:48 ET30012.32
09:57 ET50012.4
10:09 ET10012.465
10:15 ET84312.53
10:18 ET35812.51
10:20 ET27512.5
10:22 ET30012.485
10:24 ET80012.475
10:29 ET20012.43
10:31 ET10012.42
10:33 ET72512.4556
10:36 ET10012.45
10:40 ET65012.35
10:42 ET105312.365
10:47 ET294912.28
10:49 ET291512.3
10:51 ET104212.332
10:54 ET20012.32
10:56 ET20012.34
10:58 ET100612.35
11:00 ET40012.29
11:02 ET20012.29
11:03 ET37612.32
11:05 ET10012.295
11:07 ET20512.3
11:12 ET40012.28
11:14 ET100012.2401
11:16 ET11012.26
11:18 ET41512.27
11:20 ET52512.25
11:21 ET69112.3
11:23 ET40012.29
11:25 ET125012.2882
11:30 ET24812.285
11:32 ET40012.28
11:36 ET40012.27
11:38 ET66512.28
11:39 ET40012.24
11:41 ET20012.24
11:45 ET170912.31
11:52 ET42512.2857
11:54 ET30012.27
11:56 ET11412.28
11:57 ET10012.264
11:59 ET55012.26
12:01 ET47012.28
12:03 ET11212.28
12:08 ET50112.27
12:12 ET10012.28
12:14 ET589612.25
12:15 ET30012.25
12:17 ET39112.25
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBVS
Bioventus Inc
995.8M
-19.8x
---
United StatesFIGS
Figs Inc
871.6M
86.2x
---
United StatesAVNS
Avanos Medical Inc
879.6M
40.8x
---
United StatesAORT
Artivion Inc
1.2B
-1,259.5x
---
United StatesATEC
Alphatec Holdings Inc
1.4B
-8.2x
---
United StatesCSTL
Castle Biosciences Inc
852.5M
151.3x
---
As of 2024-11-29

Company Information

Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions include bone graft substitutes (BGS) that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries, as well as a portfolio of ultrasonic products used for precise bone cutting and sculpting, soft tissue management and tissue debridement in various surgeries. Its Restorative Therapies comprise a bone stimulation system, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis or other central nervous system disorders.

Contact Information

Headquarters
4721 EMPEROR BOULEVARD, SUITE 100DURHAM, NC, United States 27703
Phone
919-474-6700
Fax
302-655-5049

Executives

Non-Executive Independent Chairman of the Board
William Hawkins
President, Chief Executive Officer, Director
Robert Claypoole
Chief Financial Officer, Senior Vice President
Mark Singleton
Senior Vice President, Chief Compliance Officer
Katrina Church
Senior Vice President, General Counsel
Anthony D'adamio

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$995.8M
Revenue (TTM)
$555.1M
Shares Outstanding
81.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.80
EPS
$-0.62
Book Value
$2.20
P/E Ratio
-19.8x
Price/Sales (TTM)
1.8
Price/Cash Flow (TTM)
---
Operating Margin
-3.39%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.